AI Terminal
SEED INNOVATIONS LIMITED
Regulatory Filings • Aug 16, 2024
7909_rns_2024-08-16_c43685b0-777d-459a-bc08-8243a6dd9592.html
Regulatory Filings
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8142A
Seed Innovations Limited
16 August 2024
Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments
16 August 2024
SEED Innovations Limited
("SEED" or the "Company")
Change of Registered Address
SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, announces effective immediately a change of the registered office address of the Company, which is now Suite 8, Upper House, 16-20 Smith Street, St Peter Port, Guernsey, GY1 2JQ.
- Ends -
For further information visit: www.seedinnovations.co or contact:
| Ed McDermott Lance de Jersey |
SEED Innovations Ltd | [email protected] |
| James Biddle Roland Cornish |
Beaumont Cornish Limited Nomad |
(0)20 7628 3396 |
| Isabella Pierre Damon Heath |
Shard Capital Partners LLP Broker |
(0)20 7186 9927 |
| Ana Ribeiro Isabel de Salis |
St Brides Partners Ltd Financial PR |
[email protected] |
Notes
Seed Innovations Ltd is an AIM quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the company is agile and poised to capitalise swiftly on new investment opportunities.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CROEADPKFSDLEFA